Skip to main content

Agilent Technologies(A-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low114.91
Day High116.77
Open:116.66
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Agilent Technologies

Select a category then submit the form to load news
Tipranks
Agilent Announces Planned Retirement of Principal Accounting Officer
StockStory
1 of Wall Street’s Favorite Stock to Keep an Eye On and 2 We Find Risky
PATH
Tipranks
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS), Dyne Therapeutics (DYN) and Agilent (A)
Tipranks
Agilent Technologies Signals Steady Growth Amid Headwinds
Tipranks
Agilent (A) Receives a Buy from Wells Fargo
Tipranks
Analysts Offer Insights on Healthcare Companies: Agilent (A), Xencor (XNCR) and Pennant Group (PNTG)
Tipranks
Analysts Conflicted on These Healthcare Names: PROCEPT BioRobotics (PRCT), Soleno Therapeutics (SLNO) and Agilent (A)
Tipranks
Analysts Offer Insights on Healthcare Companies: Agilent (A), Agilon Health (AGL) and Sarepta Therapeutics (SRPT)
Tipranks
Agilent (A) Receives a Buy from Morgan Stanley
Tipranks
Agilent (A) Gets a Buy from Barclays
Stock Target Advisor
Market Analysis for February 26th, 2026
Market Analysis for February 26th, 2026
Motley Fool
Agilent (A) Q1 2026 Earnings Call Transcript
StockStory
Agilent (NYSE:A) Reports Q4 CY2025 In Line With Expectations
A
StockStory
What To Expect From Agilent’s (A) Q4 Earnings
A
StockStory
1 S&P 500 Stock to Keep an Eye On and 2 We Avoid
LEN
StockStory
3 Profitable Stocks We Steer Clear Of
IEX
Tipranks
Agilent (A) Gets a Buy from Barclays
TheNewswire.com
Metavesco Congratulates DeFi Dev Corp on Becoming the Second Publicly Traded Company to Launch a Memecoin
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agilent (A), DENTSPLY SIRONA (XRAY) and Exact Sciences (EXAS)
StockStory
3 Healthcare Stocks Walking a Fine Line
MRNA
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Agilent (A)
StockStory
Why Agilent (A) Stock Is Up Today
A
Tipranks
Analysts Offer Insights on Healthcare Companies: Agilent (A) and Tenet Healthcare (THC)
StockStory
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Ignore
AMD
Tipranks
Positive Report for Agilent (A) from Barclays
Zacks Investment Research
Strength in Technology Enabled Products Drives Roper: Can It Sustain?
Strength in Technology Enabled Products Drives Roper: Can It Sustain?
StockStory
3 Cash-Producing Stocks Walking a Fine Line
VFC
StockStory
Q3 Earnings Outperformers: Agilent (NYSE:A) And The Rest Of The Research Tools & Consumables Stocks
A
Tipranks
Morgan Stanley Ups the Ante on These 2 Life Science Tool Stocks
Tipranks
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Agilent (A)
Tipranks
Wells Fargo Reaffirms Their Buy Rating on Agilent (A)
Tipranks
Agilent Technologies Reports Strong Q4 Earnings Amid Challenges

Profile

Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.